- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02554110
Peripheral Nerve Stimulation to Reduce Hypoxic Events
November 13, 2018 updated by: Hugh M. Smith, Mayo Clinic
A Randomized Control Trial of the Oxistimulator as an Adjunct to Standard Practice to Decrease Extent and Duration of Oxygen Desaturation in Adult Patients Who Have Received Anesthetics or Are Receiving Sedating Medications
This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary effectiveness objective is to determine if transcutaneous stimulation will generate a respiratory response capable of reducing the extent and duration of oxygen desaturations in patients with presumed risk of obstructive sleep apnea (OSA) who have received some form of anesthesia or sedation.
The primary safety objective is the demonstration that the peripheral nerve stimulation is safe for the use of preventing or reducing the sedation related hypoxemic events.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria
- Males and females > 18 yrs old
- Flemon's Score > 15
- Able to provide written informed consent
- Having gynecological, colorectal, orthopedic surgery, and urologic surgeries
- Baseline oxygen saturation on room air > 96%
Exclusion Criteria:
- Peripheral neuropathy involving the upper extremities
- Procedures requiring direct admission to the ICU or any site other than the post-anesthesia care unit from the OR
- Diagnosed obstructive sleep apnea (OSA) and / or use of continuous positive airway pressure (CPAP) or biphasic positive airway pressure (BiPAP) in the PACU.
- Presence of any implantable electric devices, including internal defibrillators, pacemakers, or left ventricular assist device (LVAD)
- Post-procedure temperature < 35.5 Celsius or evidence of vasoconstriction
- Presence of metal hardware in either arm or in either shoulder
- Patients lacking access to the bare skin on an arm after surgery.
- History of atrial fibrillation
- History of bundle branch block
- Females from menarche to menopause that do not have a current negative pregnancy test or surgical history preventing pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stimulator Active Device
Intervention: This intervention arm will use a Stimulator Active Device peripheral nerve stimulation.
Participants will receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
|
This is a stimulator active device that delivers peripheral nerve stimulation in conjunction with pulse oximetry information.
|
|
Sham Comparator: Stimulator Sham Device
No intervention: This arm will use a Stimulator Sham Device peripheral nerve stimulation.Participants will not receive a cutaneous stimuli in response to oxygen desaturations in postoperative surgical patients.
|
This is an stimulator sham device that is not providing peripheral nerve stimulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Area Under the Curve for oxygen saturation (SpO2%)
Time Frame: One hour
|
One hour
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Frequency of desaturation episodes
Time Frame: One hour
|
One hour
|
|
Frequency of nursing interventions
Time Frame: One hour
|
One hour
|
|
Frequency of Adverse Events
Time Frame: 72 hours
|
72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hugh Smith, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 12, 2015
Primary Completion (Actual)
January 19, 2017
Study Completion (Actual)
January 19, 2017
Study Registration Dates
First Submitted
September 17, 2015
First Submitted That Met QC Criteria
September 17, 2015
First Posted (Estimate)
September 18, 2015
Study Record Updates
Last Update Posted (Actual)
November 15, 2018
Last Update Submitted That Met QC Criteria
November 13, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-003533
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Apnea
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
Mardin Artuklu UniversityNot yet recruitingObstructive Sleep Apnea | Sleep ApneaTurkey (Türkiye)
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); ResMed FoundationRecruitingObstructive Sleep Apnea | Sleep ApneaUnited States
-
ResMedCRI-The Clinical Research Institute GmbH; University Hospital RegensburgCompletedObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaSwitzerland, Spain, Denmark, Portugal, France, Germany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Not yet recruitingCentral Sleep Apnea | Maxillomandibular Advancement Surgery | Sleep Apnea Syndrome (OSAS) | Orthognathic Surgical ProceduresNetherlands
-
Isabel Moreno HayAmerican Academy of Dental Sleep MedicineRecruitingObstructive Sleep Apnea (SAOS) | Obstructive Sleep Apnea (OSAS)United States
-
Mayo ClinicEnrolling by invitationObstructive Sleep Apnea | OSA | Obstructive Sleep Apnea (OSA)United States
-
LivaNovaActive, not recruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
Hospices Civils de LyonNot yet recruitingObstructive Sleep ApneaFrance
Clinical Trials on Stimulator active device
-
Fisher Wallace LaboratoriesNAMSA; Climb Technologies, Inc.CompletedMajor Depressive DisorderUnited States
-
Wave NeuroscienceTexas A&M University; GilpinPhillips BIOMED, LLC; Peachtree BioResearch SolutionsCompletedTraumatic Brain Injury | PostTraumatic Stress Disorder | Postconcussive SymptomsUnited States
-
Wave NeuroscienceCompleted
-
Galvani BioelectronicsNAMSACompleted
-
Tripler Army Medical CenterUniversity of VirginiaCompletedRestless Legs SyndromeUnited States
-
Medical University of South CarolinaNational Institutes of Health (NIH); National Institute of General Medical...Completed
-
Emory UniversityCompleted
-
Azienda USL 12 VersiliaUnknownTemporomandibular Joint Disorders
-
Beijing Pins Medical Co., LtdBeijing Tiantan HospitalUnknownRefractory EpilepsyChina
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States